Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Mar 21, 2013; 19(11): 1797-1804
Published online Mar 21, 2013. doi: 10.3748/wjg.v19.i11.1797
Published online Mar 21, 2013. doi: 10.3748/wjg.v19.i11.1797
Figure 1 Five-year survival rate of the low rectal cancer patients treated with neoadjuvant chemoradiation and total mesorectal excision.
A: The 5-year overall and disease-free Kaplan-Meier survival curves; B: The 5-year disease-free survival rates of patients with tumor regression grade (TRG) 1 and TRG 2-5 are 92.3% and 63.2%, respectively; C: The 5-year disease-free survival rates of patients with positive and negative lymph node (LN) involvement are 36.5% and 76.5%, respectively.
- Citation: Lin SC, Chen PC, Lee CT, Tsai HM, Lin PC, Chen HH, Wu YH, Lin BW, Su WP, Lee JC. Routine defunctioning stoma after chemoradiation and total mesorectal excision: A single-surgeon experience. World J Gastroenterol 2013; 19(11): 1797-1804
- URL: https://www.wjgnet.com/1007-9327/full/v19/i11/1797.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i11.1797